Last updated: June 5, 2026

Back to directory

IQVIA Vigilance Detect medical AI product profile

AI-driven pharmacovigilance intake product for detecting and extracting drug safety events from multiple unstructured channels.

Screenshot of the official IQVIA Vigilance Detect product page
Medication safety and dosing

Best fit

Drug safety organizations with high-volume, multi-channel adverse-event intake that need automation while retaining qualified PV review.

Primary use case
GenAI-powered pharmacovigilance event detection and extraction from emails, audio, documents, chats, and other safety intake sources
Audience
Pharmacovigilance operations, case intake teams, safety service organizations, pharma safety leaders, and life-sciences compliance teams
Risk level
Medium to high
Pricing signal
IQVIA enterprise platform and safety-services pricing; request current Vigilance Detect, Vigilance Platform, validation, and operating model terms.
Official sources
3 official sources

Compare within workflow: Medication safety and dosing · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating IQVIA Vigilance Detect as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as safety intake and PV operations infrastructure; confirm validation, SOP alignment, inspection support, and regional reporting obligations before using automation in production.
PrivacyReview call recordings, emails, documents, chats, patient and reporter identifiers, product complaint data, translations, service access, hosting, retention, and cross-border transfer controls.
EvidenceMeasure extraction sensitivity, field-level accuracy, missed adverse events, seriousness classification, language performance, duplicate handling, follow-up burden, and reviewer acceptance locally.
WorkflowBest governed as intake acceleration with source-linked review queues, low-confidence escalation, quality sampling, medical review boundaries, and documented overrides.

Where IQVIA Vigilance Detect fits

IQVIA describes Vigilance Detect as a GenAI-powered, AI-driven pharmacovigilance platform for automatically detecting and extracting drug safety events from emails, audio, documents, and chats; IQVIA's broader safety materials describe AI, ML, NLP, connected intelligence, vigilance platform, and pharmacovigilance services.

Not for: Replacing safety specialists, bypassing medical review, or relying on extracted events without validated SOPs, quality sampling, and missed-case monitoring.

What to verify before using IQVIA Vigilance Detect

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products